These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 25986800)
1. Re: Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Assimos DG J Urol; 2015 Jun; 193(6):2008-9. PubMed ID: 25986800 [No Abstract] [Full Text] [Related]
2. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613 [TBL] [Abstract][Full Text] [Related]
3. Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Tiselius HG Urolithiasis; 2016 Feb; 44(1):91-100. PubMed ID: 26614110 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of recurrence in urolithiasis]. Terhorst B; Melchior H Z Urol Nephrol; 1969; 62(10):761-73. PubMed ID: 4326184 [No Abstract] [Full Text] [Related]
8. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol]. Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144 [TBL] [Abstract][Full Text] [Related]
9. [To what extent does a diet varying in calcium influence recurrent lithiasis in idiopathic hypercalciuria?]. Peña JC Rev Invest Clin; 2002; 54(2):105-7. PubMed ID: 12053806 [No Abstract] [Full Text] [Related]
10. Biochemical aspects of urinary stones. Rose GA Proc R Soc Med; 1977 Aug; 70(8):517-20. PubMed ID: 918063 [No Abstract] [Full Text] [Related]
11. Idiopathic hypercalciuria: can we reduce stone formation? Drug Ther Bull; 1984 Nov; 22(23):89-90. PubMed ID: 6489171 [No Abstract] [Full Text] [Related]
13. [Guidelines for prevention of recurrent urolithiasis (author's transl)]. Zechner O Wien Klin Wochenschr; 1981 Oct; 93(20):619-24. PubMed ID: 7324473 [TBL] [Abstract][Full Text] [Related]
14. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones. Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576 [TBL] [Abstract][Full Text] [Related]
15. [On the prevention of urinary calculi with ion exchangers]. Burghele T; Rugendorff EW; Covaliu T Urologe; 1967; 6(4):234-8. PubMed ID: 4872279 [No Abstract] [Full Text] [Related]
16. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Robertson WG; Peacock M Nephron; 1980; 26(3):105-10. PubMed ID: 7412965 [TBL] [Abstract][Full Text] [Related]
17. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]. Hess B Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986 [TBL] [Abstract][Full Text] [Related]
18. Recurrence prevention in patients with urinary tract stone disease. Tiselius HG ScientificWorldJournal; 2004 Jan; 4():35-41. PubMed ID: 14755100 [TBL] [Abstract][Full Text] [Related]
19. [Recurrent oxalocalcium lithiasis. 2: Risk factors and prevention of recurrence of calcium urinary lithiasis]. Réveillaud RJ; Daudon M Rev Prat; 1989 Feb; 39(4):317-23. PubMed ID: 2649970 [No Abstract] [Full Text] [Related]
20. [Basic diagnosis and conservative therapy in patients with calcium calculus diathesis]. Horn HD Dtsch Med J; 1970 Apr; 21(8):506-12. PubMed ID: 5510196 [No Abstract] [Full Text] [Related] [Next] [New Search]